Starling Oncology, Inc. (STLNW) bonds
STLNWNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31Also trades as DFPH, STLN
$0.03+0.00 (+10.87%)
Close on Oct 30, 2026Market cap $665.51MP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Total debt
$79.87M
Long-term debt
Net debt
$38.77M
After $41.09M of cash
Implied interest rate
13.22%
FY2025 interest ÷ average debt
Interest coverage
-3.2×
FY2025 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, USD
When the debt comes due
Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2025
From the debt maturity table in the annual report (filing). “Later” is everything due after year five.
Notes and loans outstanding
As tagged in Starling Oncology's 10-Q for the period ended Jun 30, 2026
| Issue | Coupon | Amount issued | Carrying value |
|---|---|---|---|
| Facility Agreement Convertible at $9 a share | 4.00% | $110.00M | $85.89M |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.